These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12599603)

  • 21. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
    Mazo EB
    Urologiia; 2001; (3):20-2. PubMed ID: 11505535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug treatment of benign prostatic hyperplasia].
    Schmid HP
    Praxis (Bern 1994); 1995 Sep; 84(39):1061-2. PubMed ID: 7481307
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
    Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G
    J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical management of benign prostatic hyperplasia--are two drugs better than one?
    Vaughan ED
    N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of benign prostatic hyperplasia.
    Walsh PC
    N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
    [No Abstract]   [Full Text] [Related]  

  • 26. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 28. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
    Taneja S
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 33. Benign prostatic hyperplasia: natural history, endocrine pathogenesis, and medical treatment with finasteride.
    Sherwood LM
    Mt Sinai J Med; 1996 Jan; 63(1):1-9. PubMed ID: 8935843
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing benign prostatic hyperplasia.
    Barkin J
    CMAJ; 1997 Apr; 156(7):978-9. PubMed ID: 9099163
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
    Bredin HC
    Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
    Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
    Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
    Lopatkin NA; Roilans PJ; Stoner E
    Urol Nefrol (Mosk); 1996; (1):2-4. PubMed ID: 8659035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
    [No Abstract]   [Full Text] [Related]  

  • 39. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
    Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finasteride therapy for benign prostatic hyperplasia.
    Helling TJ
    CMAJ; 2008 Feb; 178(5):596-7. PubMed ID: 18299551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.